Obstructive sleep apnea in severe XXXX .

@entity1 @entity162 @entity308 @entity146 @entity73 @entity27 @entity161 @entity716 @entity209 @entity25
UNASSIGNED: The prevalence of @entity27 ( @entity27 ) is estimated to be 3-7.5% in @entity1 and 2-3% in @entity1 . In mentally ill population it is even higher, as these @entity1 are a high risk @entity27 group. The aim of the paper was a review of literature about the prevalence of @entity25 in @entity1 with @entity161 , @entity162 and recurrent @entity308 .The available data show that @entity27 is present in 15-48% of @entity1 with @entity161 , 21-43% of @entity1 with @entity162 and 11-18% of @entity1 with recurrent @entity308 . The lack of diagnosis of @entity27 in @entity1 with mental illnesses has multiple negative consequences. The symptoms of @entity25 might imitate the symptoms of mental illnesses such as negative symptoms of @entity161 and symptoms of @entity308 , they might as well aggravate the @entity73 . A number of the drugs used in @entity146 may aggravate the symptoms of @entity27 . @entity27 is as well the risk factor for cardiovascular and @entity209 which are a serious clinical problem in mentally ill @entity1 and contribute to shortening of their expected lifespan. From the point of view of the physicians treating @entity27 it is important to pay attention to the fact that co-existing @entity308 is the most common reason for resistant @entity25 in @entity27 @entity1 treated effectively with Continuous Positive Airway Pressure (CPAP). CPAP therapy leads to significant improvement of mood. However, in @entity161 and @entity162 @entity1 it may rarely lead to acute worsening of mental state, exacerbation of @entity716 symptoms or phase shift from @entity308 to @entity162 .
